Table 2 Clinicopathological characteristics of 434 patients with PCa from TCGA database
| Â | Â | ARPC1A expression | Â | |
|---|---|---|---|---|
Variables | N | Low | High | P value |
Total, n (%) | 434 | 185 (42.6) | 249 (57.4) | Â |
Age, n (%) | Â | Â | Â | 0.336 |
  < 60 years | 178 (41.0) | 71 (38.4) | 107 (43.0) |  |
  ≥ 60 years | 256 (59.0) | 114 (61.6) | 142 (57.0) |  |
T Stage, n (%) |  |  |  |  < 0.001* |
 T2 | 157 (36.2) | 104 (56.2) | 53 (21.3) |  |
 T3 | 256 (59.0) | 76 (41.1) | 180 (72.3) |  |
 T4 | 21 (4.8) | 5 (2.7) | 16 (6.4) |  |
N Stage, n (%) | Â | Â | Â | 0.007* |
 N0 | 291 (67.1) | 137 (74.1) | 154 (61.8) |  |
 N1 | 143 (32.9) | 48 (25.9) | 95 (38.2) |  |
M Stage, n (%) | Â | Â | Â | 0.763 |
 M0 | 404 (93.1) | 173 (93.5) | 231 (92.8) |  |
 M1 | 30 (6.9) | 12 (6.5) | 18 (7.2) |  |
Gleason Score, n (%) | Â | Â | Â | 0.094 |
  ≤ 6 | 25 (5.8) | 14 (7.6) | 11 (4.4) |  |
 7 | 91 (21.0) | 45 (24.3) | 46 (18.5) |  |
  ≥ 8 | 301 (73.2) | 126 (68.1) | 192 (77.1) |  |
Race, n (%) | Â | Â | Â | 0.346 |
 White | 359 (82.7) | 159 (86.0) | 200 (80.4) |  |
 Yellow | 26 (6.0) | 11 (5.9) | 15 (6.0) |  |
 Black | 7 (1.6) | 2 (1.1) | 5 (2.0) |  |
 Unknown | 42 (9.7) | 13 (7.0) | 29 (11.6) |  |
Adjuvant therapy, n (%) | Â | Â | Â | 0.283 |
 Yes | 155 (35.7) | 62 (33.5) | 93 (37.3) |  |
 No | 103 (23.7) | 40 (21.6) | 63 (25.4) |  |
 Unknown | 176 (40.6) | 83 (44.9) | 93 (37.3) |  |